Statistical characteristics and correlations of histomorphometric, clinical and biochemical indices in systemic therapy in patients with osteogenesis imperfecta

Authors

  • V. V. Hryhorovskyi
  • A. M. Zyma
  • Yu. M. Guk
  • S. Mahomedov
  • O. G. Gayko
  • T. A. Kintchaia-Polishchuk

DOI:

https://doi.org/10.14739/2310-1237.2015.1.42883

Keywords:

Osteogenesis Imperfecta, Drug Therapy, Densitometry, Biochemistry, Pamidronate

Abstract

Actuality. The correlation analysis between various indices of bone tissue condition was not previously carried out in patients with osteogenesis imperfecta.

Aim. On purpose to determine differences and index correlations before and after intake of pamidronate systemic therapy in 13 patients with osteogenesis imperfecta indices of some methods including histomorphometric were studied.

Results. We found correlation parametres of biochemical indices, on one side and histomorphometric – on the other.

Conclusion. After systemic therapy mean parametres of «bone volume» in iliobiopsies increase, and «osteoid surface» and «osteoclast index per surface unit» in patients with osteogenesis imperfecta of I type – decrease, that one can regard as a tendency to improvement of the bone tissue structural-functional condition.

References

Grigorovskij, V. V., Guk, Yu. M., Magomedov, S., Stel`makh, V. V., & Zyma, A.M. (2010). Kliniko-morfologicheskie osobennosti porazheniya kostej u bol`nykh nesovershennym osteogenezom [Clinical and morphological peculiarities of bone lesions and correlations of some indices in patients with osteogenesis imperfecta]. Ortopediya, travmatologiya, protezirovanie, 1, 46–54. [in Russian].

Hryhorovskyi, V. V., Huk, Yu. M., Kinchaia-Polishchuk, T. A., Zhezhera, V. M., & Savostikova, N. L. (2005). Histolohiia ta histomorfometriia sponhiozy tazovoi kistky ditei ta pidlitkiv u normi, pry neirofibromatozi I typu ta inshykh zakhvoriuvanniakh [Histological properties and histomorphometric parameters of iliac bone spongiosa in children and adolescents in the norm, in patients with neurofibromatosis and other diseases]. Zhurnal akademii medychnykh nauk Ukrainy, 11(3), 525–539. [in Ukrainian].

Hryhorovskyi, V. V., & Zyma, A. M. (2013). Patohistolohichni vlastyvosti ta histomorfometrychni kharakterystyky hubchastoi kistkovoi tkanyny v iliobioptatakh vid khvorykh na nedoskonalyi osteohenez [Pathohistological properties and histomorphometric characteristics of cancellous bone tissue in iliobiopsies of patients with osteogenesis imperfecta]. Pathologia, 1, 71–76. [in Ukrainian].

Huk, Yu. M., Haiko, O. G., Zyma, A. M., Kinchaia-Polishchuk, T. A., & Zotia, A. V. (2014). Renthenivska densytometriia v otsintsi strukturno-funktsionalnoho stanu kistkovoi tkanyny v patsiientiv iz nedoskonalym osteohenezom [X-Ray Densitometry in Assessment of the Structural and Functional State of Bone in the Patients with Osteogenesis Imperfecta]. Bol`. Sustavy. Pozvonochnik, 1–2, 42–46. [in Ukrainian].

Krys-Puhach, A. P., Huk, Yu. M., Mahomedov, O. M., Zyma, A. M., Kinchaia-Polishchuk, T. A., & Zotia, A. V. (2013) Metabolizm kistkovoi tkanyny u khvorykh na nedoskonalyi osteohenez [Bone tissue metabolism in patients with osteogenesis imperfecta]. Problemy osteolohii, 16(3), 18–21. [in Ukrainian].

Povoroznyuk, V. V., Grechanina, Ye. Ya., Balackaya, Ye. I., & Vajda, V. M. (2009) Nesovershennyj osteogenez: patogenez, klassifikaciya, klinicheskaya kartina, lechenie [Osteogenesis imperfecta: pathogenesis, classification, clinical presentation, treatment]. Ortopediya, travmatologiya, protezirovanie, 4, 110–117. [in Russian].

Khurana, J. S., & Fitzpatrick, L. A. (2009). Osteoporosis and Metabolic Bone Disease. JBone Pathology. S. Khurana (Ed.). Heidelberg: Humana Press, 217–237.

Kocijan, R., Muschitz, Ch., Haschka, J., & Resch, H. (2013) An update on osteogenesis imperfecta. Problemy osteologii, 16(2), 3–16.

Munns, C. F. J., Rauch, F., Travers, R., & Glorieux, F. H. (2005) Effects of Intravenous Pamidronate Treatment in Infants With Osteogenesis Imperfecta: Clinical and Histomorphometric Outcome. J. Bone and Miner. Res., 20(7), 1235–1243.

Rauch, F. Travers, R., & Glorieux, F. H. (2006) Pamidronate in Children with Osteogenesis Imperfecta: Histomorphometric Effects of Long-Term Therapy. J. Clin. Endocrin. and Metab., 91(2), 511–516. doi:10.1210/jc.2005-2036.

Downloads

How to Cite

1.
Hryhorovskyi VV, Zyma AM, Guk YM, Mahomedov S, Gayko OG, Kintchaia-Polishchuk TA. Statistical characteristics and correlations of histomorphometric, clinical and biochemical indices in systemic therapy in patients with osteogenesis imperfecta. Pathologia [Internet]. 2015May19 [cited 2024Nov.24];(1). Available from: http://pat.zsmu.edu.ua/article/view/42883

Issue

No. 1 (2015)

Section

Original research

License

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Лицензия Creative Commons
    1. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

  1. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).